Back to Results
First PageMeta Content
Lactams / PDE5 inhibitors / Piperazines / Sexual health / Eli Lilly and Company / Tadalafil / Prostaglandin E1 / Erectile dysfunction / CGMP-specific phosphodiesterase type 5 / Medicine / Chemistry / Organic chemistry


Microsoft Word - FINAL MSD Report dated 1 March[removed]Web version.doc
Add to Reading List

Open Document

File Size: 954,92 KB

Share Result on Facebook

City

Wellington / /

Company

Accident Compensation Corporation / NZHTA Health / New Zealand Accident Compensation Corporation / Medline / /

Country

New Zealand / /

/

Facility

University of Otago / Canterbury Medical Library / University of Otago NEW ZEALAND HEALTH TECHNOLOGY ASSESSMENT / /

/

IndustryTerm

search strategy / TREATMENT OF ERECTILE DYSFUNCTION / treatment of male claimants with erectile dysfunction / economics search / literature search / treatment for ACC claimants whose erectile dysfunction / treatment for men whose erectile dysfunction / vacuum constriction device / /

Organization

Division of Health Sciences / University of Otago / IN MEN / Sarah Hogan New Zealand Health Technology Assessment Department of Public Health / Public Health and General Practice Christchurch School of Medicine / University of Otago NEW ZEALAND HEALTH TECHNOLOGY ASSESSMENT / Research Unit / Ministry of Health / Public Health and General Practice Christchurch School of Medicine Christchurch / Department of Public Health / /

Person

Ally Reid / Ray Kirk / Sarah Hogan / Margaret Paterson / Claire Stewart / /

/

Position

Economist / Administrative Secretary / Director / Information Specialist / EXECUTIVE / physician / Researcher / NZHTA Administrative Secretary / NZHTA Information Specialist / /

Product

INTRACAVERNOUS INJECTIONS / Intracavernosal injection / /

Technology

HEALTH TECHNOLOGY / /

URL

http /

SocialTag